Balversa 4 MG
Ended Awarded
- Contract number
- 36C24524N0813
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,643
Award facts
- Contract value 100% obligated
- $17,642.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a pharmaceutical manufacturer, to provide BALVERSA 4 MG, a cancer treatment drug, to the U.S. Department of Veterans Affairs (VA). The contract is a delivery order with a firm fixed price of $17,642.95 and an ultimate completion date of August 13, 2024. This award is associated with two larger contract vehicles - a $3.7 million single-award Blanket Purchase Agreement (BPA) established in August 2020 and a $3.1 billion multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs awarded in September 2019. These contracts enable various Veterans Integrated Service Networks (VISNs) within the VA's Veterans Health Administration (VHA) to efficiently procure critical oncology medications to support healthcare services for veterans across the country. The contract award does not have a set-aside designation.
Quick answers
Who was awarded contract 36C24524N0813?
36C24524N0813 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 8, 2024.
How much is contract 36C24524N0813 worth?
The government has obligated $17,643 on 36C24524N0813.
Is contract 36C24524N0813 an order under another contract?
Yes. 36C24524N0813 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0813 competed?
The extent of competition for 36C24524N0813 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award